CompletedNot Applicable

Melanoma Risk Assessment & Tailored Intervention

United States323 participantsStarted 2011-05

Plain-language summary

The investigators are conducting a study to provide evidence about the comparative effectiveness of mailed, tailored intervention materials on cancer prevention behavioral outcomes. The investigators will send out three (3) tailored mailings for participants who are assigned to the intervention group. Second, during the eligibility screening, the investigators will be assessing the relative yield and functioning of two risk assessment tools (BRAT and FEARS) on determining an individual's level of risk for skin cancer.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subjects are capable of giving informed consent
✓. Subjects are ≥ 18 years old.
✓. Subjects are English speaking and can read English
✓. Subjects must meet all criteria listed in Phase I.
✓. Subjects are identified as Caucasian.
✓. Subjects must be at moderate or high risk for skin cancer, based on scores from the BRAT and Fears combined risk assessment.

Exclusion criteria

✕. Children under the age of 18 will not be included.
✕. For Phase II, previously diagnosed with melanoma.
✕. For Phase II, planning to be away for three (3) consecutive weeks or longer in June, July, or August

What they're measuring

Compare the effects of offering tailored print materials to that of generic print materials on perceived risk of melanoma, sun avoidance/protection, and skin self-examination behaviors.

Timeframe: 3-6 months total per participant

Trial details

NCT IDNCT01356771

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-02

View on ClinicalTrials.gov More Melanoma trials